- Home
- UHT vs SLP Comparison
UHT vs SLP Comparison
Compare UHT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHT
- SLP
- Stock Information
- Founded
- UHT 1986
- SLP 1996
- Country
- UHT United States
- SLP United States
- Employees
- UHT N/A
- SLP N/A
- Industry
- UHT Real Estate Investment Trusts
- SLP EDP Services
- Sector
- UHT Real Estate
- SLP Technology
- Exchange
- UHT Nasdaq
- SLP Nasdaq
- Market Cap
- UHT 566.7M
- SLP 261.0M
- IPO Year
- UHT N/A
- SLP 1997
- Fundamental
- Price
- UHT $38.56
- SLP $13.06
- Analyst Decision
- UHT
- SLP Buy
- Analyst Count
- UHT 0
- SLP 7
- Target Price
- UHT N/A
- SLP $29.50
- AVG Volume (30 Days)
- UHT 56.3K
- SLP 1.0M
- Earning Date
- UHT 07-28-2025
- SLP 07-14-2025
- Dividend Yield
- UHT 7.63%
- SLP N/A
- EPS Growth
- UHT N/A
- SLP N/A
- EPS
- UHT 1.30
- SLP N/A
- Revenue
- UHT $99,952,000.00
- SLP $80,383,000.00
- Revenue This Year
- UHT $3.87
- SLP $19.69
- Revenue Next Year
- UHT $3.97
- SLP $6.95
- P/E Ratio
- UHT $30.95
- SLP N/A
- Revenue Growth
- UHT 0.31
- SLP 20.01
- 52 Week Low
- UHT $34.56
- SLP $12.39
- 52 Week High
- UHT $47.30
- SLP $42.11
- Technical
- Relative Strength Index (RSI)
- UHT 33.23
- SLP 28.76
- Support Level
- UHT $40.24
- SLP $12.97
- Resistance Level
- UHT $41.99
- SLP $13.84
- Average True Range (ATR)
- UHT 0.88
- SLP 0.76
- MACD
- UHT -0.23
- SLP 0.30
- Stochastic Oscillator
- UHT 2.00
- SLP 12.50
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.